Spyre Therapeutics Stock (NASDAQ: SYRE) stock price, news, charts, stock research, profile.
Open | $29.95 |
Close | $30.95 |
Volume / Avg. | 722.96K / 601.65K |
Day Range | 29.78 - 31.14 |
52 Wk Range | 10.42 - 47.97 |
Market Cap | $1.57B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 18.56% |
Days to Cover | 4.3 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Spyre Therapeutics (NASDAQ:SYRE) through any online brokerage.
Other companies in Spyre Therapeutics’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Immatics (NASDAQ:IMTX), Prothena Corp (NASDAQ:PRTA), Arcutis Biotherapeutics (NASDAQ:ARQT) and Day One Biopharmaceutical (NASDAQ:DAWN).
There is no analysis for Spyre Therapeutics.
Spyre Therapeutics has a consensus price target of $43.17.
The stock price for Spyre Therapeutics (NASDAQ: SYRE) is $30.95 last updated Today at July 16, 2024 at 4:52 PM EDT.
There are no upcoming dividends for Spyre Therapeutics.
Spyre Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Spyre Therapeutics.
Spyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.